R&D innovation biotechnology enterprise in China. The company's ecosystem spans biological research, in vitro diagnostics and biomedicine. Vazyme has created eight series of proprietary POCT diagnostic reagents and related controls for diagnosing cardiovascular and cerebrovascular disease, inflammatory, autoimmune, chronic and respiratory diseases, prepotency, and functional gastrointestinal and renal diseases.